News
Academy
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Latest Executive Roundtables
  • Asembia 2025
  • Sales Effectiveness
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Article

May 8, 2015

Research Shows Link Between Patient Recruitment Methods and Retention

Author(s):

Applied Clinical Trials Editorial Staff

Research from MediciGlobal shows that patients who actively sought clinical trial involvement through its online recruitment model had a 38% lower relative risk of drop out across four studies compared to those who were recruited by sites, with divergence across visits.

Research from MediciGlobal shows that patients who actively sought clinical trial involvement through its online recruitment model had a 38% lower relative risk of drop out across four studies compared to those who were recruited by sites, with divergence across visits. The primary outcome for the meta-analysis measure was retention rates of subjects recruited comparing the two methods of engagement, online versus site databases.  A secondary outcome was retention rates across all study visits to determine divergence patterns between the two groups.

The firm noted in a press release that higher retention levels of subjects actively engaged in seeking out a clinical trial compared to those who were passively engaged via the physician or study staff may be related to different motivations between the groups of patients. This may be due to the company's online process in which patients seeking the study online must also undergo a comprehensive vetting procedure. The company says additional research is necessary to further understand the drivers of these differences. 

 

Read the full release here.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Related Content
Advertisement
An RNA-Guided Path
August 28th 2025

An RNA-Guided Path

Mike Hollan
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
August 28th 2025

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
Driving Disruption in Delivery
August 28th 2025

Driving Disruption in Delivery

Mike Hollan
Determined Problem-Solver
August 28th 2025

Determined Problem-Solver

Mike Hollan
Ahmet Tutuncu
August 28th 2025

Creating Momentum for COPD Treatments: Q&A with Dr. Ahmet Tutuncu

Mike Hollan
Shweta Maniar
August 28th 2025

The Reality of AI: Q&A with Shweta Maniar

Mike Hollan
Related Content
Advertisement
An RNA-Guided Path
August 28th 2025

An RNA-Guided Path

Mike Hollan
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
August 28th 2025

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
Driving Disruption in Delivery
August 28th 2025

Driving Disruption in Delivery

Mike Hollan
Determined Problem-Solver
August 28th 2025

Determined Problem-Solver

Mike Hollan
Ahmet Tutuncu
August 28th 2025

Creating Momentum for COPD Treatments: Q&A with Dr. Ahmet Tutuncu

Mike Hollan
Shweta Maniar
August 28th 2025

The Reality of AI: Q&A with Shweta Maniar

Mike Hollan
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.